“…As reported by Schwarz et al (2021) , compared with the healthy condition, the lipid mediators and eicosanoids were disturbed, including decreased products of ALOX12 (e.g., 12-HEPE, 12-HETE, RvE3, and LXA4) and COX2 (e.g., PGE2, PGD2, PGF2a, TXB2, and 18-HEPE), increase products of ALOX5 (e.g., RvD1-4, LTB4, 5-HEPE, 5-HETE, 7-HDHA, and 7-HDPA), and cytochrome p450 (5,6 DiHETrE, 8,9 DiHETrE, 11,12 DiHETrE, and 14,15 DiHETrE) in human serum. Besides, plasma metabolic results identified 18 metabolites (e.g., LTB4, 9,10-DiHOME, 12,13-DiHOME, PGE2, and PGD2) with statistically significant differences ( p < 0.01) with more than four-fold change between healthy controls ( n = 44) and COVID-19 patients ( n = 6) ( McReynolds et al, 2021 ). Much works, either in vitro or in vivo , may be necessitated to evaluate metabolomic characteristics under virus attack.…”